3-Hydroxyphencyclidine (3-HPC), a breakdown product of phencyclidine (PCP), is growing attracting clinical scrutiny due to limited evidence suggesting different pharmacological properties. Preliminary research suggest https://www.pinterest.com/pin/1140888518124046392/